[
  {
    "ts": "2025-09-22T16:03:00+00:00",
    "headline": "SNY & REGN's Dupixent Receives CHMP Backing for Urticaria in EU",
    "summary": "Sanofi/Regeneron's Dupixent wins CHMP backing for chronic spontaneous urticaria in the EU, paving the way for expanded treatment options.",
    "url": "https://finance.yahoo.com/news/sny-regns-dupixent-receives-chmp-160300944.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "cc89d6fe-c442-363e-9814-0a6bcec5bead",
      "content": {
        "id": "cc89d6fe-c442-363e-9814-0a6bcec5bead",
        "contentType": "STORY",
        "title": "SNY & REGN's Dupixent Receives CHMP Backing for Urticaria in EU",
        "description": "",
        "summary": "Sanofi/Regeneron's Dupixent wins CHMP backing for chronic spontaneous urticaria in the EU, paving the way for expanded treatment options.",
        "pubDate": "2025-09-22T16:03:00Z",
        "displayTime": "2025-09-22T16:03:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/4c89fa4c828d913dc49739912177a966",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o4IYsXmA1G0eGuhNw0c16g--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4c89fa4c828d913dc49739912177a966.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/43AXa9s.CTUHOV5OT2wzjA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4c89fa4c828d913dc49739912177a966.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sny-regns-dupixent-receives-chmp-160300944.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sny-regns-dupixent-receives-chmp-160300944.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SAN.PA"
            },
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-22T13:35:12+00:00",
    "headline": "Humana initiated, Paycom upgraded: Wall Street's top analyst calls",
    "summary": "Humana initiated, Paycom upgraded: Wall Street's top analyst calls",
    "url": "https://finance.yahoo.com/news/humana-initiated-paycom-upgraded-wall-133512545.html",
    "source": "The Fly",
    "provider": "yfinance",
    "raw": {
      "id": "576a5b9a-5f79-38f4-bedd-3982a2f6231c",
      "content": {
        "id": "576a5b9a-5f79-38f4-bedd-3982a2f6231c",
        "contentType": "STORY",
        "title": "Humana initiated, Paycom upgraded: Wall Street's top analyst calls",
        "description": "",
        "summary": "Humana initiated, Paycom upgraded: Wall Street's top analyst calls",
        "pubDate": "2025-09-22T13:35:12Z",
        "displayTime": "2025-09-22T13:35:12Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec",
          "originalWidth": 1200,
          "originalHeight": 628,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YHTvjvqtNAYBPYViMXYCow--~B/aD02Mjg7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec.cf.webp",
              "width": 1200,
              "height": 628,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J3gfZRz3Jb2im4_aLYVn4g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Fly",
          "url": "https://thefly.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/humana-initiated-paycom-upgraded-wall-133512545.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/humana-initiated-paycom-upgraded-wall-133512545.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NTRA"
            },
            {
              "symbol": "GH"
            },
            {
              "symbol": "R"
            },
            {
              "symbol": "FDS"
            },
            {
              "symbol": "LEN"
            },
            {
              "symbol": "LEN-B"
            },
            {
              "symbol": "EG"
            },
            {
              "symbol": "IRM"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "KDP"
            },
            {
              "symbol": "KLAC"
            },
            {
              "symbol": "EAT"
            },
            {
              "symbol": "CROX"
            },
            {
              "symbol": "PAYC"
            },
            {
              "symbol": "AMAT"
            },
            {
              "symbol": "HUM"
            },
            {
              "symbol": "LRCX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-22T04:29:00+00:00",
    "headline": "Dupixent® (dupilumab) to Treat Chronic Spontaneous Urticaria (CSU) Advances in EU with Positive CHMP Opinion",
    "summary": "Recommendation for adults and adolescents based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo If approved, Dupixent would be the first targeted medicine in over a decade indicated for CSU in the European Union (EU) TARRYTOWN, N.Y. and PARIS, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP)",
    "url": "https://finance.yahoo.com/news/dupixent-dupilumab-treat-chronic-spontaneous-042900405.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "f6bf827e-f4c1-3e32-b099-9bf0ed44ff53",
      "content": {
        "id": "f6bf827e-f4c1-3e32-b099-9bf0ed44ff53",
        "contentType": "STORY",
        "title": "Dupixent® (dupilumab) to Treat Chronic Spontaneous Urticaria (CSU) Advances in EU with Positive CHMP Opinion",
        "description": "",
        "summary": "Recommendation for adults and adolescents based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo If approved, Dupixent would be the first targeted medicine in over a decade indicated for CSU in the European Union (EU) TARRYTOWN, N.Y. and PARIS, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP)",
        "pubDate": "2025-09-22T04:29:00Z",
        "displayTime": "2025-09-22T04:29:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/2788fcd6c9b4dcf523fc2cc341eb4142",
          "originalWidth": 800,
          "originalHeight": 126,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ohIVokMiKClSVTQVwyB2lw--~B/aD0xMjY7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2788fcd6c9b4dcf523fc2cc341eb4142.cf.webp",
              "width": 800,
              "height": 126,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YuYzNeQcIK6rRYN1HdT6UA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2788fcd6c9b4dcf523fc2cc341eb4142.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/dupixent-dupilumab-treat-chronic-spontaneous-042900405.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/dupixent-dupilumab-treat-chronic-spontaneous-042900405.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            },
            {
              "symbol": "SNY"
            },
            {
              "symbol": "SNYNF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]